(24/7 MARKET NEWS) – HeartBeam, Inc. (NASDAQ: BEAT) announced that it was issued a patent for its 12-lead electrocardiogram (ECG) patch monitor, intended for detection of acute coronary syndrome (ACS) and cardiac arrhythmia, by the United States Patent and Trademark Office. The patent opens a pathway to a disruptive Ischemia and Arrhythmia detection product.
It’s trading a dime below yesterday’s close, at $1.93, up $0.68 (+54.40%), on 6.3 million premarket shares.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.